Pre-Eclampsia Screen with Papp-A and PLGF
This screening test assesses the risk of preeclampsia in pregnancy by measuring PAPP-A and PlGF levels in maternal serum. It helps in early identification of women at risk for complications.
No special preparations needed
- Pregnancy Associated Plasma Protein (papp-a)
- Placental Growth Factor (plgf)
- Uterine Arterial Pulsatility Index (utpi)
- Mean Arterial Pressure (map)
- Corrected Papp-a Mom
- Corrected Plgf Mom
- Corrected Utpi Mom
- Corrected Map Mom
- Preeclampsia Screening < 32 Week
- Preeclampsia Screening < 34 Week
- Preeclampsia Screening < 37 Week
Test code
10869
Specimen vol. and vacutainer information
| Specimen | Vacutainer | Volume |
|---|---|---|
| Serum | Yellow Vacutainer | 3 ML |
Specimen stability information
Serum
Collection instructions
Risk assessment is calculated between gestation 11-14.1 weeks in first trimester. Referring physicians name, contact detail and duly filled Maternal consent form is mandatory (Maternal Date of Birth,Maternal Weight, Maternal Race, duplicate readings of blood pressure for both arms, left and right pulsatility index (UTPI),Maternal H/O Type I Diabetes Mellitus + Obstetric USG Report between 11 to 13.6 weeks of gestation+Date of collection).
Specimen rejection criteria
Test run frequency
Tuesday,Friday TIME - 09:00
Turn around time
5 Working Days
Performing locations
Department
- Endocrinology
CPT and Loinc codes
Package price
₹3000
Need Help?
Talk to our health experts for guidance on tests, reports, or bookings.
WhatsApp to Book TestPre-Eclampsia Screen with Papp-A and PLGF
₹3000